1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porters Fiver Forces Analysis 36
3 Segmentation of Asia Pacific Market by Source 40
3.1 Market Overview by Source 40
3.2 Human 42
3.3 Humanized 43
3.4 Chimeric 44
3.5 Murine 45
4 Segmentation of Asia Pacific Market by Category 46
4.1 Market Overview by Category 46
4.2 Branded mAbs 48
4.3 Biosimilar mAbs 49
5 Segmentation of Asia Pacific Market by Production Type 50
5.1 Market Overview by Production Type 50
5.2 In Vitro Production 52
5.3 In Vivo Production 53
6 Segmentation of Asia Pacific Market by Application 54
6.1 Market Overview by Application 54
6.2 Cancer 56
6.2.1 Breast Cancer 58
6.2.2 Colorectal Cancer 59
6.2.3 Lung Cancer 60
6.2.4 Ovarian Cancer 61
6.2.5 Other Cancer Types 62
6.3 Autoimmune Diseases 63
6.4 Inflammatory Diseases 64
6.5 Infectious Diseases 65
6.6 Other Applications 66
7 Segmentation of Asia Pacific Market by End User 67
7.1 Market Overview by End User 67
7.2 Hospitals 69
7.3 Research Institutes 70
7.4 Other End Users 71
8 Asia-Pacific Market 2019-2030 by Country 72
8.1 Overview of Asia-Pacific Market 72
8.2 Japan 75
8.3 China 78
8.4 Australia 80
8.5 India 82
8.6 South Korea 84
8.7 Rest of APAC Region 86
9 Competitive Landscape 88
9.1 Overview of Key Vendors 88
9.2 New Product Launch, Partnership, Investment, and M&A 91
9.3 Company Profiles 92
Abbott Laboratories 92
AbbVie, Inc. 94
Amgen Inc. 95
AstraZeneca plc 96
Bayer AG 97
Bristol-Myers Squibb Company 98
Eli Lilly 99
F. Hoffmann-La Roche Ltd. 100
GlaxoSmithKline Plc 101
Johnson & Johnson 102
Merck & Co., Inc. 103
Mylan N.V 104
Norvatis AG 105
Pfizer 106
Sanofi S.A. 107
RELATED REPORTS 108